Sources, distribution, bioavailability, toxicity, and risk assessment of heavy metal(loid)s in complementary medicines

Shiv Bolan, Anitha Kunhikrishnan, Balaji Seshadri, Girish Choppala, Ravi Naidu, Nanthi S. Bolan, Yong Sik Ok, Ming Zhang, Chun Guang Li, Feng Li, Barry Noller, Mary Beth Kirkham

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

The last few decades have seen the rise of alternative medical approaches including the use of herbal supplements, natural products, and traditional medicines, which are collectively known as ‘Complementary medicines’. However, there are increasing concerns on the safety and health benefits of these medicines. One of the main hazards with the use of complementary medicines is the presence of heavy metal(loid)s such as arsenic (As), cadmium (Cd), lead (Pb), and mercury (Hg). This review deals with the characteristics of complementary medicines in terms of heavy metal(loid)s sources, distribution, bioavailability, toxicity, and human risk assessment. The heavy metal(loid)s in these medicines are derived from uptake by medicinal plants, cross-contamination during processing, and therapeutic input of metal(loid)s. This paper discusses the distribution of heavy metal(loid)s in these medicines, in terms of their nature, concentration, and speciation. The importance of determining bioavailability towards human health risk assessment was emphasized by the need to estimate daily intake of heavy metal(loid)s in complementary medicines. The review ends with selected case studies of heavy metal(loid) toxicity from complementary medicines with specific reference to As, Cd, Pb, and Hg. The future research opportunities mentioned in the conclusion of review will help researchers to explore new avenues, methodologies, and approaches to the issue of heavy metal(loid)s in complementary medicines, thereby generating new regulations and proposing fresh approach towards safe use of these medicines.

Original languageEnglish
Pages (from-to)103-118
Number of pages16
JournalEnvironment International
Volume108
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Complementary Therapies
Heavy Metals
Biological Availability
bioavailability
risk assessment
heavy metal
toxicity
medicine
Arsenic
Cadmium
arsenic
cadmium
traditional medicine
Traditional Medicine
Insurance Benefits
Medicinal Plants
Biological Products
Mercury
medicinal plant
health and safety

Keywords

  • Bioavailability
  • Complementary medicines
  • Heavy metal(loid)s
  • Risk assessment
  • Toxicity

ASJC Scopus subject areas

  • Environmental Science(all)

Cite this

Bolan, S., Kunhikrishnan, A., Seshadri, B., Choppala, G., Naidu, R., Bolan, N. S., ... Kirkham, M. B. (2017). Sources, distribution, bioavailability, toxicity, and risk assessment of heavy metal(loid)s in complementary medicines. Environment International, 108, 103-118. https://doi.org/10.1016/j.envint.2017.08.005

Sources, distribution, bioavailability, toxicity, and risk assessment of heavy metal(loid)s in complementary medicines. / Bolan, Shiv; Kunhikrishnan, Anitha; Seshadri, Balaji; Choppala, Girish; Naidu, Ravi; Bolan, Nanthi S.; Ok, Yong Sik; Zhang, Ming; Li, Chun Guang; Li, Feng; Noller, Barry; Kirkham, Mary Beth.

In: Environment International, Vol. 108, 01.01.2017, p. 103-118.

Research output: Contribution to journalReview article

Bolan, S, Kunhikrishnan, A, Seshadri, B, Choppala, G, Naidu, R, Bolan, NS, Ok, YS, Zhang, M, Li, CG, Li, F, Noller, B & Kirkham, MB 2017, 'Sources, distribution, bioavailability, toxicity, and risk assessment of heavy metal(loid)s in complementary medicines', Environment International, vol. 108, pp. 103-118. https://doi.org/10.1016/j.envint.2017.08.005
Bolan, Shiv ; Kunhikrishnan, Anitha ; Seshadri, Balaji ; Choppala, Girish ; Naidu, Ravi ; Bolan, Nanthi S. ; Ok, Yong Sik ; Zhang, Ming ; Li, Chun Guang ; Li, Feng ; Noller, Barry ; Kirkham, Mary Beth. / Sources, distribution, bioavailability, toxicity, and risk assessment of heavy metal(loid)s in complementary medicines. In: Environment International. 2017 ; Vol. 108. pp. 103-118.
@article{f1bfd2ef8a314a4790d4e1524ccda43e,
title = "Sources, distribution, bioavailability, toxicity, and risk assessment of heavy metal(loid)s in complementary medicines",
abstract = "The last few decades have seen the rise of alternative medical approaches including the use of herbal supplements, natural products, and traditional medicines, which are collectively known as ‘Complementary medicines’. However, there are increasing concerns on the safety and health benefits of these medicines. One of the main hazards with the use of complementary medicines is the presence of heavy metal(loid)s such as arsenic (As), cadmium (Cd), lead (Pb), and mercury (Hg). This review deals with the characteristics of complementary medicines in terms of heavy metal(loid)s sources, distribution, bioavailability, toxicity, and human risk assessment. The heavy metal(loid)s in these medicines are derived from uptake by medicinal plants, cross-contamination during processing, and therapeutic input of metal(loid)s. This paper discusses the distribution of heavy metal(loid)s in these medicines, in terms of their nature, concentration, and speciation. The importance of determining bioavailability towards human health risk assessment was emphasized by the need to estimate daily intake of heavy metal(loid)s in complementary medicines. The review ends with selected case studies of heavy metal(loid) toxicity from complementary medicines with specific reference to As, Cd, Pb, and Hg. The future research opportunities mentioned in the conclusion of review will help researchers to explore new avenues, methodologies, and approaches to the issue of heavy metal(loid)s in complementary medicines, thereby generating new regulations and proposing fresh approach towards safe use of these medicines.",
keywords = "Bioavailability, Complementary medicines, Heavy metal(loid)s, Risk assessment, Toxicity",
author = "Shiv Bolan and Anitha Kunhikrishnan and Balaji Seshadri and Girish Choppala and Ravi Naidu and Bolan, {Nanthi S.} and Ok, {Yong Sik} and Ming Zhang and Li, {Chun Guang} and Feng Li and Barry Noller and Kirkham, {Mary Beth}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.envint.2017.08.005",
language = "English",
volume = "108",
pages = "103--118",
journal = "Environmental International",
issn = "0160-4120",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Sources, distribution, bioavailability, toxicity, and risk assessment of heavy metal(loid)s in complementary medicines

AU - Bolan, Shiv

AU - Kunhikrishnan, Anitha

AU - Seshadri, Balaji

AU - Choppala, Girish

AU - Naidu, Ravi

AU - Bolan, Nanthi S.

AU - Ok, Yong Sik

AU - Zhang, Ming

AU - Li, Chun Guang

AU - Li, Feng

AU - Noller, Barry

AU - Kirkham, Mary Beth

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The last few decades have seen the rise of alternative medical approaches including the use of herbal supplements, natural products, and traditional medicines, which are collectively known as ‘Complementary medicines’. However, there are increasing concerns on the safety and health benefits of these medicines. One of the main hazards with the use of complementary medicines is the presence of heavy metal(loid)s such as arsenic (As), cadmium (Cd), lead (Pb), and mercury (Hg). This review deals with the characteristics of complementary medicines in terms of heavy metal(loid)s sources, distribution, bioavailability, toxicity, and human risk assessment. The heavy metal(loid)s in these medicines are derived from uptake by medicinal plants, cross-contamination during processing, and therapeutic input of metal(loid)s. This paper discusses the distribution of heavy metal(loid)s in these medicines, in terms of their nature, concentration, and speciation. The importance of determining bioavailability towards human health risk assessment was emphasized by the need to estimate daily intake of heavy metal(loid)s in complementary medicines. The review ends with selected case studies of heavy metal(loid) toxicity from complementary medicines with specific reference to As, Cd, Pb, and Hg. The future research opportunities mentioned in the conclusion of review will help researchers to explore new avenues, methodologies, and approaches to the issue of heavy metal(loid)s in complementary medicines, thereby generating new regulations and proposing fresh approach towards safe use of these medicines.

AB - The last few decades have seen the rise of alternative medical approaches including the use of herbal supplements, natural products, and traditional medicines, which are collectively known as ‘Complementary medicines’. However, there are increasing concerns on the safety and health benefits of these medicines. One of the main hazards with the use of complementary medicines is the presence of heavy metal(loid)s such as arsenic (As), cadmium (Cd), lead (Pb), and mercury (Hg). This review deals with the characteristics of complementary medicines in terms of heavy metal(loid)s sources, distribution, bioavailability, toxicity, and human risk assessment. The heavy metal(loid)s in these medicines are derived from uptake by medicinal plants, cross-contamination during processing, and therapeutic input of metal(loid)s. This paper discusses the distribution of heavy metal(loid)s in these medicines, in terms of their nature, concentration, and speciation. The importance of determining bioavailability towards human health risk assessment was emphasized by the need to estimate daily intake of heavy metal(loid)s in complementary medicines. The review ends with selected case studies of heavy metal(loid) toxicity from complementary medicines with specific reference to As, Cd, Pb, and Hg. The future research opportunities mentioned in the conclusion of review will help researchers to explore new avenues, methodologies, and approaches to the issue of heavy metal(loid)s in complementary medicines, thereby generating new regulations and proposing fresh approach towards safe use of these medicines.

KW - Bioavailability

KW - Complementary medicines

KW - Heavy metal(loid)s

KW - Risk assessment

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=85027855385&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027855385&partnerID=8YFLogxK

U2 - 10.1016/j.envint.2017.08.005

DO - 10.1016/j.envint.2017.08.005

M3 - Review article

C2 - 28843139

AN - SCOPUS:85027855385

VL - 108

SP - 103

EP - 118

JO - Environmental International

JF - Environmental International

SN - 0160-4120

ER -